The approach to reperfusion treatments in acute ischemic stroke continues to evolve and neuroimaging is becoming more and more important in the diagnostic work-up and clinical decisions. “Imaging is brain” is replacing “Time is brain” and is bringing a renewed interest in the state of the ischemic tissue and therefore in preclinical research. Preclinical research could help understanding the neuronal and vascular underpinnings of futile recanalization, identify potential treatment targets and lead to clinical translation. See the attached flyer for invited speakers, topics, and final programme.
Registration is free of charge. The participation in the webinar delivers 4,5 ECM.
TRANSLATIONAL RESEARCH on STROKE – TReeS –
Workshop
Hot topics in acute stroke: from bedside to bench and back again
October 19, 2021
10.00 am – 1.30 pm
Program
| hour | time | Topic | speaker |
| 10.00 | 10’ | Welcome and Introduction | Marzia Baldereschi
Cristina Sarti |
| Chairs M. Baldereschi and C. Sarti | |||
| 10.15 | 30’ | Opening Lecture:
Stroke: from therapeutic nihilism to precision medicine |
Domenico Inzitari |
| 10.45 | 15’ | Advanced Neuroimaging in stroke clinical practice | Enrico Fainardi |
| 11.00 | 15’ | New frontiers in stroke neuroimaging | James Kennedy |
| Chairs A.L. Allegra Mascaro and E. Conti | |||
| 11.15 | 15’ | MRI in preclinical stroke research | Rick Dijkhuizen |
| 11.30 | 15’ | Advanced optical imaging in preclinical stroke research | Adam Bauer |
| 11.45 | 5’ | STROKELAB2BED project in a nutshell and preliminary results | Emilia Conti e
Benedetta Piccardi |
| 11.50 | 5’ | NIMBLE project in a nutshell and preliminary results | Alessandro Sodero |
| Chairs B. Giusti,A. Gori, B.Piccardi | |||
| 12.00 | 15’ | Blood Biomarkers in acute ischemic stroke | Alejandro Bustamante |
| 12.15 | 15’ | Plasticity of the brain -from mesoscale to cellular levels- to restore sensorimotor and cognitive functions after stroke | Ann-Sophie Wahl |
| 12.30 | 30’ | Lecture:
Immune biomarkers and neuroprotection |
Josef Anrather |
| 1.00 pm | 20’ | Epigenetic Pathways as Molecular and Druggable Targets in Stroke, and conclusive remarks | Lucio Annunziato |
